Skip to content

About Us
Our Science
Pipeline
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs

About Us
Our Science
Pipeline
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs

About Us
Our Science
Pipeline
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs

About Us
Our Science
Pipeline
Investors
- Overview
- News
- Events
- Stock Information
- Filings
- Corporate Governance
- FAQs

News

Select Year
Clinical Trials
Search …

December 2, 2014

Oncolytics Biotech® Inc. Announces Filing for Orphan Drug Designation with the U.S. FDA for Pancreatic and Ovarian Cancers

November 18, 2014

Media Advisory – Oncolytics Biotech® Inc. to Participate in the Stifel 2014 Healthcare Conference

November 6, 2014

Oncolytics Biotech® Inc. Announces Third Quarter 2014 Results

November 4, 2014

Oncolytics Biotech® Inc. Announces Receipt of Nasdaq Notice of Deficiency

October 24, 2014

Oncolytics Biotech® Inc. Announces Entry Into $20 Million “At-The-Market” Equity Distribution Agreement with Canaccord Genuity Inc.

October 20, 2014

Oncolytics Biotech® Inc. Announces Amendment to Common Share Purchase Agreement with Lincoln Park Capital Fund, LLC

September 16, 2014

Oncolytics Biotech® Inc. Announces Overall and KRAS-Mutated Patient Data from U.S. Randomized Phase 2 Pancreatic Cancer Study

September 3, 2014

/C O R R E C T I O N from Source — Oncolytics Biotech Inc./

September 2, 2014

Media Advisory – Oncolytics Biotech® Inc. to Participate in the Baird 2014 Health Care Conference

August 11, 2014

Media Advisory – Oncolytics Biotech® Inc. Announces Participation in Upcoming Conferences

Page 43 of 71

Investor Relations Contact

Jon Patton
Director of Investor Relations & Communication
Email: jpatton@oncolytics.com

Email Alerts Sign-Up

Email

I accept the Privacy Policy

Loading...

4350 Executive Drive
Suite 325
San Diego, CA 92121
info@oncolyticsbiotech.com

Company

Our Mission
Leadership
Board of Directors
Careers
Contact

Science

Our Science
Pipeline
Resources

Investors

Overview
News
Events
Stock Information
Filings
Corporate Governance
FAQs

Privacy Policy Accessibility Cookie Policy Disclaimer Manage Consent

Copyright © 2026 Oncolytics Biotech Inc.